Skip to main content
OpenTrials

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

1,466 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma

NCT00052936

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +27 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • II. Medizinische Klinik Aschaffenburg, Germany
View all 174 locations
View Trial Details
Completed

Rituximab and Combination Chemotherapy in Treating Older Patients With Previously Untreated B-Cell Lymphoma

NCT00290667

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
Locations
  • University Hospital Brno Brno, Czechia
  • Charles University Hospital Prague, Czechia
  • Hopital Debrousse Lyon, France
  • Haematologisch Onkologische Praxis Aachen, Germany
View all 338 locations
View Trial Details
Completed

Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma

NCT00053768

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +22 more
Locations
  • Haematologisch Onkologische Praxis Aachen, Germany
  • Klinikum St. Marien Amberg, Germany
  • Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany
  • Specialist Practice for Oncology Aschaffenburg, Germany
View all 175 locations
View Trial Details
Completed

FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma

NCT01410630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center - University of Texas Houston, Texas, United States
  • Aachen University Aachen, Germany
View Trial Details
Completed

Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma

NCT01742988

Conditions
Double-expressor Lymphoma (DEL), Double-hit Lymphoma (DHL), Hemic and Lymphatic Diseases, +18 more
Locations
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • University of Chicago Medicine Chicago, Illinois, United States
View Trial Details

Related conditions